The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: infliximab, recombinant     Quarter: 2016Q3

Total Records: 276     Number of Pages: 14

DRUGNAME PT EventCount
INFLIXIMAB, RECOMBINANT Herpes simplex 1
INFLIXIMAB, RECOMBINANT Herpes virus infection 1
INFLIXIMAB, RECOMBINANT Horner's syndrome 1
INFLIXIMAB, RECOMBINANT Hyperhidrosis 1
INFLIXIMAB, RECOMBINANT Hypertensive crisis 1
INFLIXIMAB, RECOMBINANT Hypotension 1
INFLIXIMAB, RECOMBINANT Ileal stenosis 1
INFLIXIMAB, RECOMBINANT Immune reconstitution inflammatory syndrome associated tuberculosis 1
INFLIXIMAB, RECOMBINANT Immunosuppression 1
INFLIXIMAB, RECOMBINANT Inflammatory bowel disease 1
INFLIXIMAB, RECOMBINANT Injection site reaction 1
INFLIXIMAB, RECOMBINANT Interstitial lung disease 1
INFLIXIMAB, RECOMBINANT Intestinal ischaemia 1
INFLIXIMAB, RECOMBINANT Intestinal obstruction 1
INFLIXIMAB, RECOMBINANT Intestinal ulcer 1
INFLIXIMAB, RECOMBINANT Iron deficiency anaemia 1
INFLIXIMAB, RECOMBINANT Kidney duplex 1
INFLIXIMAB, RECOMBINANT Latent tuberculosis 1
INFLIXIMAB, RECOMBINANT Lower respiratory tract infection 1
INFLIXIMAB, RECOMBINANT Lung disorder 1

Total Records: 276     Number of Pages: 14